Table 2.
Putative QTL identified for STB resistance.
| Putative QTL | Map position | Number of MTAs | Flanking markers | Chr | Phenotypes | Year data |
|---|---|---|---|---|---|---|
| qSTB.1 | 67.7–69.2 | 1 (6) | IACX3496 / Kukri_c10239_2186 | 1A | SDS at heading | Combined (2012) |
| qSTB.2 | 85.8 | 1 | Jagger_c9472_305 | 2B | SDS at heading | Combined |
| qSTB.3 | 71.6–72.5 | 9 (1) | wsnp_Ex_c3478_6369892/ wsnp_RFL_Contig4404_5157920 | 3A | SPC | Combined (2012) |
| qSTB.4 | 167.5 | 1 | Excalibur_c113341_139 | 4A | SPC | Combined |
| qSTB.5 | 135.2 | 1 | Tdurum_contig10210_425 | 5A | SPC | 2013 |
The name, map position (in cM), the number of MTAs, flanking markers, chromosome (Chr), measured phenotype, and year of the data originating the putative QTL are given for each entry. In case the putative QTL derives from multiple datasets, the number of MTAs and the year data for the alternative dataset is given in brackets. SDS, Septoria disease severity; SPC, Septoria progress coefficient.